Outcome Rights Issue
Immunicum’s rights issue of approximately SEK 111 million, which ended on June 14, 2016, was oversubscribed. In view of the strong demand from both new and existing shareholders the over-allotment option has been exercises in part, amounting to approximately SEK 17 million. Immunicum’s proceeds of the issue thereby totaled approximately SEK 128 million before transaction costs.
Read the press release here: Press release 160621 – Outcome rights issue